ClinicalTrials.gg
Status unknownNCT04020354EarlyHABIT-ILEUpdated May 25, 2022

Changes Induced by Early HABIT-ILE in Pre-school Children With Uni- and Bilateral Cerebral Palsy

An interventional study of HABIT-ILE and Usual Care in Cerebral Palsy, sponsored by Université Catholique de Louvain. Status unknown at 3 sites in 3 countries. Open to participants aged 12 Months to 59 Months. Per ClinicalTrials.gov, last updated 2022-05-25.

Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
12 Months to 59 Months
Sex
All
01

Study summary

Studying in two randomized controlled trials (RCT) the changes induced by early HABIT-ILE in functional, neuroplastic and biomechanical assessment in children with unilateral and bilateral CP.

Read the detailed description

This study aims to evaluate the effect of two weeks of early Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) on bimanual performance in pre-school children with unilateral cerebral palsy (CP) and on gross motor function in those with bilateral CP, compared with two weeks of usual motor activity including usual rehabilitation (control group). We will assess further changes in unilateral performance tests, daily life activities questionnaires and executive function tests. Neuroplastic changes will be assessed using brain imaging (magnetic resonance imaging, MRI) and biomechanical changes will be assessed by using optoelectronic motion capture system with electromyography (EMG), to determine the effect of HABIT-ILE on movement pattern and quality.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • motor skill learning
  • functional changes
  • neuroplastic changes
  • biomechanical changes
03

In context

Cerebral Palsy

1,891 studies on the registry are indexed under Cerebral Palsy; 439 are open to participants now.

This study's planned enrollment of 100 is above the median of 34 across 1,396 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Université Catholique de Louvain is the lead sponsor of 151 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Months to 59 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children with unilateral or bilateral cerebral palsy (spastic or dyskinetic)
  • age 1 to 4 years inclusive (corrected age if preterm birth)
  • ability to follow instructions and complete testing according to the age.

Exclusion criteria

Exclusion Criteria:

  • active seizure
  • programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time
  • severe visual impairments
  • severe cognitive impairments
  • contraindications to perform MRI assessments (Metal implants, etc.)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    HABIT-ILE

    Early HABIT-ILE (Hand and arm bimanual intensive therapy including lower extremities) will be applied over 2 weeks.

    Behavioral: HABIT-ILE

  • Active comparator
    Usual Care

    A two weeks period of usual customary care

    Behavioral: Usual Care

Interventions

  • BehavioralHABIT-ILE

    Early Hand and arm bimanual intensive therapy including lower extremities

  • BehavioralUsual Care

    Usual customary care

06

What researchers measure

Primary outcomes

  1. Change on Gross Motor Function (GMFM-66)

    Developed to assess the changes in gross motor function of children with cerebral palsy (scored in percentage), observed over time or after intervention for the second randomized controlled trial (RCT2)

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up.

  2. Change on Manual Ability (Assisting Hand Assessment (AHA))

    Developed to observe the efficacy of the assisting hand use, in children with unilateral cerebral palsy (scored in percentage), during bimanual activities for the first randomized controlled trial (RCT1)

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

Secondary outcomes

  1. Melbourne 2 Assessment (MA2)

    assess the unilateral performance of the upper extremities, quantifying the dexterity, fluency, accuracy and range of movement during several tasks of reaching and manipulation

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  2. Inhibitory control task

    Measures the inhibition of a motor answer. It's assessed by asking the child not to reach for a toy previously showed to play with. The maximum waiting time is 30 seconds.

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  3. Working memory task

    Measures the capacity to retain visual information in use, in a short period of time. It's assessed by hiding a toy in front of the child and asking him/her to find it from 4 possibilities.

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  4. Visuo-spatial attention assessment

    Through different simple tasks, measures the visual field, the visuo-motor coordination, the orientation of attention in the space and the eye pursuit.

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  5. Semmes-Weinstein monofilaments

    Evaluates the pressure threshold or the response to a touching sensation of the filament. It is quantified using a numerical grading ranging from high pression/clear touching sensation to a slight pression/slight touching sensation.

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  6. Pressure Threshold

    The superior pressure threshold will be determined at the moment of any visible change in the child's reaction to the pression made by the algometer.

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  7. Activlim-CP questionnaire

    This parent's filled questionnaire measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower extremities through 43 items specific to patients with cerebral palsy. It ranges from - 7 to +7 logits (higher score means better performance).

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  8. Pediatric Evaluation of Disability Inventory questionnaire (PEDI)

    This parent's filled questionnaire measures the performance of the child in the daily life activities and movement domains, focusing on the capacity of upper extremities and lower extremities during this activities. It ranges from 0 to 100% (higher score means better performance).

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  9. Young children's participation and environment measure (YC-PEM)

    Based in different children's activities, this parent's filled questionnaire evaluates the level of participation and the quality of the environment in which these activities take place. For each type of activity, caregivers assess 3 dimensions of the child's participation: frequency (8-point scale; 0-7), level of involvement (5-point scale; 1-5), caregiver's percent desire for change (2-points level (y/n) transformed in percentage; 0-100) and perceived impact of environmental support (3-point scale transformed in percentage; 0-100). A software calculates the total score with a maximum of 212 (higher score means better performance).

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  10. Measure of Processes of Care (MPOC-20)

    Assesses the parents' perceptions of the care they and their children receive from children's rehabilitation treatment centres. Using a 8-point response scale, parents answer to 20 questions, indicating to what extent they have experienced the events or the situations described. A score of 7 means that they have experienced this aspect to a very great extent, or most of the time. A score of 1 means that they have not experienced this aspect at all. A score of 0 means that the question does not apply to them. There is no total score. However, because the statements are positively worded, higher total scores indicates that needs of the parents are being met to a great extent.

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  11. Canadian Occupational Performance Measure (COPM)

    This is an interview-setting designed to capture a patient's self-perception of performance and satisfaction of it in everyday activities, observed over time. During the interview, parents set up 5 activities considered difficult in daily life. These are then assessed, in a 1 to 10 scale, regarding the child's self-perception of performance and satisfaction of it. The total score is the average of the scores for perception and satisfaction separately (score from 1 to 10; higher score means better performance/satisfaction)

    Time frame: pre-camp, two weeks post-camp, 3 months follow-up

  12. 3D T1-weighted structural imaging (T1)

    This sequence allows to measure changes in gray matter (cortical thickness)

    Time frame: pre-camp, 3 months follow-up

  13. Changes on the Fractional Anisotropy (Diffusion tensor imaging (DTI))

    This sequence allows to measure changes in the fractional anisotropy (FA) on the white matter tracts. FA is a scalar value (no unit) between zero and one that describes the degree of anisotropy of white matter water molecules.

    Time frame: pre-camp, 3 months follow-up

  14. Changes on the Mean Diffusivity (Diffusion tensor imaging (DTI))

    This sequence allows to measure the mean changes in the diffusivity (MD). MD is a scalar value (no unit) between zero and one that describes the degree of molecular diffusion.

    Time frame: pre-camp, 3 months follow-up

  15. Changes on resting state functional connectivity (RS)

    Resting-state functional magnetic resonane imaging (rs-fMRI) evaluates the regional interactions that occur during the resting or task-negative state. The magnitud of the brain activation during rs-fMRI will be assessed

    Time frame: pre-camp, 3 months follow-up

  16. Changes on spatial parameters of the gait (Kinematics assessments)

    Through a 3D motion system, we measure the stride length (meters), step length (meters) and step width (meters).

    Time frame: pre-camp, 3 months follow-up

  17. Changes on temporal parameters of the gait (Cycle time)

    Through a 3D motion system, we measure cycle of gait time (seconds).

    Time frame: pre-camp, 3 months follow-up

  18. Changes on temporal parameters of the gait (Stance time)

    Through a 3D motion system, we measure the stance time (percentage of total gait cycle).

    Time frame: pre-camp, 3 months follow-up

  19. Changes on temporal parameters of the gait (Swing time)

    Through a 3D motion system, we measure the swing time (percentage of total gait cycle).

    Time frame: pre-camp, 3 months follow-up

  20. Changes on temporal parameters of the gait (Stride)

    Through a 3D motion system, we measure the gait cadence (stride per minute).

    Time frame: pre-camp, 3 months follow-up

  21. Changes on temporal parameters of the gait (Velocity)

    Through a 3D motion system, we measure the gait velocity (meter/second)

    Time frame: pre-camp, 3 months follow-up

  22. Changes on temporal parameters of the gait (Acceleration)

    Through a 3D motion system, we measure the gait acceleration (meters/second\^2)

    Time frame: pre-camp, 3 months follow-up

  23. Changes on spatial parameters of the upper extremity (Straightness)

    Through a 3D motion system, we measure the straightness (percentage of upper extremity trajectory during a reaching task).

    Time frame: pre-camp, 3 months follow-up

  24. Changes on spatial parameters of the upper extremity (Smoothness)

    Through a 3D motion system, we measure the smoothness (variability of the movement during a reaching task)

    Time frame: pre-camp, 3 months follow-up

  25. Changes on temporal parameters of the upper extremity (Kinematics assessments)

    Through a 3D motion system, we measure the time from onset to end of the task (seconds). the task consist in a reaching task.

    Time frame: pre-camp, 3 months follow-up

  26. Quantification of physical activity

    With a movement sensor on each wrist, the percentage of total time spent in movement (i.e. crawling, walking and running) is measured. Calculated in terms of the changes in the acceleration (m/s\^2). These measurements will be performed during therapy in 5 consecutive days for the HABIT-ILE group and during a regular week for the Usual Care group.

    Time frame: 5 hours during 5 consecutive days

07

Study locations

3 sites
  • Institute of Neuroscience, Université catholique de Louvain
    Brussels, 1200, Belgium
  • Fondation ILDYS - Site de Ty Yann
    Brest, France
  • IRCCS Fondazione Stella Maris
    Tirrenia, Tuscany 56128, Italy
08

References and documents

Publications

  • Araneda R, Ebner-Karestinos D, Paradis J, Klocker A, Saussez G, Demas J, Bailly R, Bouvier S, Carton de Tournai A, Herman E, Souki A, Le Gal G, Nowak E, Sizonenko SV, Newman CJ, Dinomais M, Riquelme I, Guzzetta A, Brochard S, Bleyenheuft Y. Changes Induced by Early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities in Young Children With Unilateral Cerebral Palsy: A Randomized Clinical Trial. JAMA Pediatr. 2024 Jan 1;178(1):19-28. doi: 10.1001/jamapediatrics.2023.4809. PubMed 37930692 ↗
  • Araneda R, Sizonenko SV, Newman CJ, Dinomais M, Le Gal G, Nowak E, Guzzetta A, Riquelme I, Brochard S, Bleyenheuft Y; Early HABIT-ILE group. Functional, neuroplastic and biomechanical changes induced by early Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (e-HABIT-ILE) in pre-school children with unilateral cerebral palsy: study protocol of a randomized control trial. BMC Neurol. 2020 Apr 14;20(1):133. doi: 10.1186/s12883-020-01705-4. PubMed 32290815 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2018 to primary completion in Dec 2021, 37 months.

Of 882 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 37 months is above that.

Counting every sponsor, half of 900 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2018
First posted
Jul 16, 2019
StartActual
Nov 27, 2018
Primary completionActual
Dec 31, 2021
CompletionEst.
Jun 30, 2022
Last update
May 25, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04020354
Collaborators
University Hospital, Brest, University of Pisa, University Hospital, Angers, University of Lausanne Hospitals, University of the Balearic Islands, Fondation Paralysie Cérébrale
Responsible party
Yannick Bleyenheuft (Professor, Université Catholique de Louvain) — Principal investigator
First posted
Jul 16, 2019
Start date
Nov 27, 2018
Primary completion
Dec 31, 2021
Completion
Jun 30, 2022 (estimated)
Last update
May 25, 2022

Study contacts

Yannick Bleyenheuft, Pr
principal investigator · MSL-IN Lab, Institute of Neuroscience, Université catholique de Louvain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion